Targeting protein prenylation for cancer therapy

Berndt, Norbert, Hamilton, Andrew D., Sebti, Saïd M.·2011·Nature Reviews Cancer

Cited by (622)

Items 401–500 of 622

  1. Protective effects of intrathecal injection of AAV9-RabGGTB-GFP+ in SOD1G93A mice
    Tianchu Gao, Jia Huo, Cheng Xin, Jing Yang, Qi Liu, Hui Dong, Rui Li, Yaling Liu · 2023 · Frontiers in Aging Neuroscience
  2. Manumycin induces apoptosis in prostate cancer cells
    Miaorong She, Jing-Gao Li, Ciyong Lu, Shanshan Wei, Ping-Fang Xia, Zesheng Lu, Qi Peng · 2014 · OncoTargets and Therapy
  3. K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions
    Sara Chiblak, Brigitte Steinbauer, Andrea Pohl–Arnold, Dagmar Kucher, Amir Abdollahi, Christian Schwager, Birgit Höft, Iréne Esposito, Karin Müller‐Decker · 2016 · Scientific Reports
  4. Protein Lipidation As a Regulator of Apoptotic Calcium Release: Relevance to Cancer
    Jessica Jie Chen, Darren F. Boehning · 2017 · Frontiers in Oncology
  5. A Guanidyl‐Based Bivalent Peptidomimetic Inhibits K‐Ras Prenylation and Association with c‐Raf
    Mai Tsubamoto, Toan Khanh Le, Minghua Li, Taku Watanabe, Chiemi Matsumi, Prakash T. Parvatkar, Hiroshi Fujii, Nobuo Kato, Jiazhi Sun, Junko Ohkanda · 2019 · Chemistry - A European Journal
  6. Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer
    Yanbo Pan, Olena Berkovska, Soumitra Marathe, Georgios Mermelekas, Greta Gudoitytė, Amare Desalegn Wolide, Taner Arslan, Brinton A. Seashore-Ludlow, Janne Lehtiö, Lukas M. Orre · 2025 · iScience
  7. Emerging drugs for Epstein-Barr virus associated-diseases
    Nassima Oumata, Qian Zhong, Yongmin Zhang, Hervé Galons, Graciela Andreï, Mu‐Sheng Zeng · 2025 · European Journal of Medicinal Chemistry
  8. KRAS Inhibition in Pancreatic Ductal Adenocarcinoma
    Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary Phillip Yeung, Madappa N. Kundranda · 2026 · Journal of Clinical Medicine
  9. Emerging anti‐HDV drugs and HBV cure strategies with anti‐HDV activity
    Armando Andres Roca Suarez, Enkhtuul Batbold, Birke Bartosch, Naranjargal Dashdorj, Barbara Testoni, Fabien Zoulim · 2023 · Liver International
  10. Small‐Molecule Modulation of Protein Lipidation: From Chemical Probes to Therapeutics
    Zhen Wang, Jiafu Ying, Xuanpu Zhang, Miao Chen, Yu Xiao, Jie Zou, Baoen Chen · 2023 · ChemBioChem
  11. CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
    Mithila Tennakoon, Waruna Thotamune, John L. Payton, Ajith Karunarathne · 2023 · Journal of Biological Chemistry
  12. Selective Gas-Phase Oxidation and Localization of Alkylated Cysteine Residues in Polypeptide Ions via Ion/Ion Chemistry
    Alice L. Pilo, Feifei Zhao, Scott A. McLuckey · 2016 · Journal of Proteome Research
  13. Investigational drugs in development for Hepatitis D
    Mario Rizzetto · 2017 · Expert Opinion on Investigational Drugs
  14. Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism
    Maryam Zamanian-Daryoush, Daniel J. Lindner, Jennifer A. Buffa, Banu Gopalan, Jie Na, Stanley L. Hazen, Joseph A. DiDonato · 2020 · Oncotarget
  15. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
    Antonella Catalano, Mojca Adlesic, Thorsten Kaltenbacher, Rhena F. U. Klar, Joachim Albers, Philipp Seidel, Laura P. Brandt, Tomáš Hejhal, Philipp Busenhart, Niklas Röhner et al. · 2021 · Cancers
  16. Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
    Ritu Kulshrestha, Pawan Kumar, Amit Singh, K. Nupur, Sonam Spalgias, Parul Mrigpuri, Rajkumar · 2021 · Molecular Biomedicine
  17. Cytotoxic Effect of Fluvastatin on MCF-7 Cells Possibly Through a Reduction of the mRNA Expression Levels of SGK1 and CAV1
    Osman Şalış, Abdülkerim Bedir, Sedat GÜLTEN, Ali Okuyucu, Canan Kulcu, Hasan Alaçam · 2014 · Cancer Biotherapy and Radiopharmaceuticals
  18. MAX-ing Out MYC: A Novel Small Molecule Inhibitor Against MYC-Dependent Tumors
    Iok In Christine Chio, G. Yordanov, David Arthur Tuveson · 2014 · JNCI Journal of the National Cancer Institute
  19. General Physiology and Pathophysiology of Microglia During Neuroinflammation
    Ishan Kumar Patro, Aarti Nagayach, Shrstha Sinha, Nisha Patro · 2016 · Springer eBooks
  20. [Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma].
    Yu-sui Chang, Jichun Liu, Hua-Qun Fu, Bentong Yu, Shubing Zou, Qicai Wu, Li Wan · 2013 · PubMed
  21. Platinum( iv ) combo prodrugs containing cyclohexane-1 R ,2 R -diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer
    Elisabetta Gabano, Marzia Bruna Gariboldi, Emanuela Marras, Francesca Barbato, Mauro Ravera · 2023 · Dalton Transactions
  22. Quantitative Determination of Cellular Farnesyltransferase Activity: Towards Defining the Minimum Substrate Reactivity for Biologically Relevant Protein Farnesylation
    Susan Flynn, Danielle E. Lindgren, James L. Hougland · 2014 · ChemBioChem
  23. Chemical Proteomic Profiling of the Interacting Proteins of Isoprenoid Pyrophosphates
    Rong Cai, Xuejiao Dong, Kailin Yu, Xiaomei He, Xiaochuan Liu, Yinsheng Wang · 2020 · Analytical Chemistry
  24. Environmentally sensitive fluorescent probes with improved properties for detecting and imaging PDEδ in live cells and tumor slices
    Keliang Li, Shanchao Wu, Gaopan Dong, Yu Li, Wei Wang, Guoqiang Dong, Zhanying Hong, Minyong Li, Chunquan Sheng · 2023 · Chinese Chemical Letters
  25. Lonafarnib Is a Potential Inhibitor for Neovascularization
    Linlin Sun, Songbo Xie, Guoyuan Peng, Jian Wang, Yuanyuan Li, Juan Qin, Diansheng Zhong · 2015 · PLoS ONE
  26. Synthesis and screening of peptide libraries with free C-termini.
    Yen-Chih Wang, Mark Dewey Distefano · 2014 · PubMed
  27. Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation
    Hiu Yeung Lau, Mei Wang · 2017 · Small GTPases
  28. Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib
    Bisheng Liu, Xin‑Yu Dai, Hongwei Xia, Huanji Xu, Qiulin Tang, Qiyong Gong, Yongzhan Nie, Feng Bi · 2018 · Molecular Medicine Reports
  29. Fluvastatin is effective against thymic carcinoma
    Keitaro Hayashi, Yoshimasa Nakazato, Noriaki Morito, Mizuki Sagi, Tomoe Fujita, Naohiko Anzai, Masayuki Chida · 2019 · Life Sciences
  30. HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
    Anna Di Benedetto, Marcella Mottolese, Francesca Sperati, Cristiana Ercolani, Luigi Di Lauro, Laura Pizzuti, Patrizia Vici, Irene Terrenato, Abeer M. Shaaban, Sreekumar Sundara‐Rajan et al. · 2016 · Scientific Reports
  31. Simultaneous Analysis of a Non-Lipidated Protein and Its Lipidated Counterpart: Enabling Quantitative Investigation of Protein Lipidation’s Impact on Cellular Regulation
    Agnesa Shala, Melanie J. Blanden, Svetlana M. Krylova, Soumyashree A. Gangopadhyay, Stanislav S. Beloborodov, James L. Hougland, Sergey N. Krylov · 2017 · Analytical Chemistry
  32. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
  33. pH-Degradable Polyglycerol-Based Nanogels for Intracellular Protein Delivery
    Sebastian Schötz, Björn B. Goerisch, Alexandros Mavroskoufis, Mathias Dimde, Elisa Quaas, Katharina Achazi, Rainer Haag · 2023 · ACS Applied Nano Materials
  34. Probing Colocalization of N‐Ras and K‐Ras4B Lipoproteins in Model Biomembranes
    Lie Li, Mridula Dwivedi, Satyajit Patra, Nelli Erwin, Simone Möbitz, Roland Winter · 2019 · ChemBioChem
  35. Post-translational lipid modifications in Plasmodium parasites
    Natalie A. Counihan, Hope C Chernih, Tania F. de Koning‐Ward · 2022 · Current Opinion in Microbiology
  36. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry
    Emilio Camafeita, Inmaculada Jorge, José Rivera, Vicente Andrés, Jesús Vázquez · 2022 · International Journal of Molecular Sciences
  37. Selective Disruption of Rb–Raf-1 Kinase Interaction Inhibits Pancreatic Adenocarcinoma Growth Irrespective of Gemcitabine Sensitivity
    Jose Gilberto Trevino, Monika Verma, Sandeep Singh, Smitha Pillai, Dongyu Zhang, Daniele Pernazza, Saı̈d M. Sebti, Nicholas J. Lawrence, Barbara Ann Centeno, Srikumar Chellappan · 2013 · Molecular Cancer Therapeutics
  38. Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening
    Xiaojuan Yu, Xue Zhi Zhao, Lili Zhu, Chuanxin Zou, Xiaofeng Liu, Zhenjiang Zhao, Jin Yan Huang, Honglin Li · 2013 · MedChemComm
  39. Bioblockades join the assault on small G protein signalling
    Helen R. Mott, Darerca Owen · 2018 · Seminars in Cancer Biology
  40. Metabolic Response of Pancreatic Carcinoma Cells under Treatment with Dichloroacetate
    Benedikt Feuerecker, Philipp Biechl, Christian Veltkamp, Dieter Saur, Wolfgang Eisenreich · 2021 · Metabolites
  41. Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer
    Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung et al. · 2021 · Cancer Research and Treatment
  42. Microglia in the Physiology and Pathology of Brain
    Aarti Nagayach, Nisha Patro, Ishan Kumar Patro · 2015 · Proceedings of the National Academy of Sciences India Section B Biological Sciences
  43. Design, synthesis and biological evaluation of new Myo-inositol derivatives as potential RAS inhibitors
    Javeena Hussain, Dimple Chhabria, Sivapriya Kirubakaran · 2020 · Bioorganic & Medicinal Chemistry Letters
  44. CDK6: an attractive therapeutic target for T-ALL/LBL
    Wei Li, Jamie Katy Hu, Miaofen G. Hu · 2023 · Expert Opinion on Therapeutic Targets
  45. Drugging Ras trafficking—are there new roads to travel?
    Elisabeth Schaffner‐Reckinger, Atanasio Gómez‐Mulas, Daniel Abankwa · 2025 · npj Drug Discovery.
  46. Structure–activity relationship study to improve cytotoxicity and selectivity of lonafarnib against breast cancer cells
    Siriwat Hongnak, Ronald Gust · 2023 · Archiv der Pharmazie
  47. Targeting lipid metabolism overcomes BTK inhibitor resistance in diffuse large B-cell lymphoma
    Zhuojun Liu, Chenyue Wu, Zhaohua Yao, Yuxuan Wang, Zhe Yu, Jian Yu · 2024 · Medicine in Novel Technology and Devices
  48. NRAS palmitoylation and oncogenic fitness
    Lucio Hernán Castilla · 2020 · Blood
  49. RAS: Circuitry and therapeutic targeting
    Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
  50. Cholesterol metabolism on stem cell fate determination: a frontier horizon
    Boyang Xu, Ling Li, Qian Wei, Yuli Wang, He Huang, Tao Pang, Zhijian Wei, Guo‐qing Zheng, Yue Li · 2025 · Stem Cell Research & Therapy
  51. Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Qi Cheng, Jing Qin Wu, Yingqian Xia, Qing Cheng, Yinjuan Zhao, Peixiang Zhu, Wangling Zhang, Shihu Zhang, Lei Zhang, Yushan Yuan et al. · 2023 · Molecular Brain
  52. DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers
    Guangli Nie, Shiyun Chen, Qingzhi Song, Dongxu Zou, Maggie Li, Xiyu Tang, Yuanlian Deng, Bizhou Huang, Mengxia Yang, Guoqing Lv et al. · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
  53. Everolimus for astrocytomas in tuberous sclerosis complex
    Birgit Geoerger, Heike Blockus · 2012 · The Lancet
  54. Synthesis of structural analogues of GGT1-DU40, a potent GGTase-1 inhibitor
    Muhammad Mansha, Nisar Ullah, Khalid Rashed Alhooshani · 2016 · Zeitschrift für Naturforschung B
  55. Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation
    Jordan M. Dailey, Sydney Ann Kee, Anuj Tharakan, Aslamuzzaman Kazi, Jason R. Burchett, Elizabeth Motunrayo Kolawole, William Ballance, Aditya Kotha, Quang Le, Lawrence B. Schwartz et al. · 2023 · The Journal of Immunology
  56. Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
    Yuda Zhang, Fanxu Zeng, Shixuan Peng, Yangqian Chen, Wenjuan Jiang, Zhan Wang, Deng Li, Zhe Huang, Haoyue Qin, Huan Yan et al. · 2023 · Expert Review of Respiratory Medicine
  57. Structural And Computational Perspectives of Selectively Targeting Mutant Proteins
    Matt Coban, Sarah Fraga, Thomas R. Caulfield · 2020 · Current Drug Discovery Technologies
  58. Concomitant Acute Tubular Necrosis and Acute Interstitial Nephritis Induced by Tipifarnib in a Patient with Squamous Cell Carcinoma of the Lung.
    P. Martínez de la Cruz, A. Shabaka, X. Mielgo-Rubio, C. Guerrero-Márquez, Sara Giménez-Moyano, G. Fernandez-Juárez · 2021 · American Journal of the Medical Sciences
  59. Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling
    Nazarius Saah Lamango, Augustine T. Nkembo, Elizabeth Ntantie, Nada Tawfeeq · 2020 · Current Medicinal Chemistry
  60. Transport to Rhebpress activity
    Amanda Garrido, Marta Brandt, Nabil Djouder · 2016 · Small GTPases
  61. In Vivo Metabolic Labeling with an Isoprenoid Probe Reveals APOE Allele-Specific Differences in the Prenylome
    Alexandru Mihai Petre, Josslen S. Thieschafer, Charuta C. Palsuledesai, Katie Cornille, Allison Chang, Ling Li, Mark Dewey Distefano · 2025 · ACS Chemical Biology
  62. The impact of epigenetics on tumor metabolism: Friend or foe in drug response?
    Serena Castelli, M. Franchini, Luigi Ferraro, Nicolò Mangraviti · 2026 · Frontiers in epigenetics and epigenomics
  63. Organotellurium Probes Enable One-step Single-cell Analysis of Post-translational Modification
    Yuanzhe Chen, Kris Elbein, Sneha Venkatachalapathy, Ellen Lorimer, Andrea M. Sprague-Getsy, Shelby A. Auger, Zoë A. Maxwell, Mohammad Rashidian, James L. Hougland, Carol L. Williams et al. · 2026 · Journal of the American Chemical Society
  64. KRAS: Structure, function, and development of anticancer drugs
    Dolly A. Parasrampuria, Alex Yu, Nahor Haddish‐Berhane · 2020 · Elsevier eBooks
  65. Quadruplex nucleic acids in KRAS targeted-cancer therapy
    Luigi Emilio Xodo · 2020 · Annual reports in medicinal chemistry
  66. Geranylgeranylation signaling promotes breast cancer cell mitosis via the YAP-activated transcription of kinetochore/centromere genes.
    Jing Wei, Song Xia, Aiqin Sun, Yaping Qu, Jinyi Gao, Genbao Shao, Wannian Yang, Qiong Lin · 2022 · PubMed Central
  67. Combining Isoprenoid Probes with Antibody Markers for Mass Cytometric Analysis of Prenylation in Single Cells
    Zoë A. Maxwell, Kiall F. Suazo, Heather M. Brown, Mark Dewey Distefano, Edgar A. Arriaga · 2022 · Analytical Chemistry
  68. Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors
    Prajna Tripathi, Rajni Kumari, Rajiv Pathak · 2024 · International review of cytology
  69. Characterization and functional analysis of novel α-bisabolol synthase (MrBAS) promoter from Matricaria recutita
    Jiarui Zheng, Nuo Wang, Weiwei Zhang, Yongling Liao, Tingting Tao, Jie Chang, Jiabao Ye, Feng Xu, Qijian Wang, Leiyu Jiang et al. · 2024 · International Journal of Biological Macromolecules
  70. Cholesterol metabolism and tumor radiotherapy
    Hao Kuang, Jia-Hua Lyu, Tao Li · 2023 · journal of nutritional oncology
  71. MAP Kinase Pathway
    Jacques Robert · 2014 · Springer eBooks
  72. Characterization of the promoter of the human farnesyltransferase beta subunit and the impact of the transcription factor OCT-1 on its expression
    Henning Verhasselt, Patrick Stelmach, Marie Domin, Dominik Jung, Anna Hagemann, Iris Manthey, Hagen S. Bachmann · 2022 · Genomics
  73. Cholesterol Drugs Improve Breast Cancer Prognosis in Women with Diabetes Mellitus
    Chi‐Chen Hong · 2013 · Advances in Pharmacoepidemiology & Drug Safety
  74. ram1 gene, encoding a subunit of farnesyltransferase, contributes to growth, antifungal susceptibility to amphotericin B of Aspergillus fumigatus
    Jianjun Qiao, Yan Song, Zongxin Ling, Xia Liu, Hong Fang · 2017 · Medical Mycology
  75. Lonafarnib synergizes with azoles against Aspergillus spp. and Exophiala spp.
    Jianjun Qiao, Yi Sun, Lujuan Gao, Chengyan He, Wenqian Zheng · 2017 · Medical Mycology
  76. The Endeavours in RAS Inhibition - the Past, Present, and Future
    Javeena Hussain, Sivapriya Kirubakaran, Srimadhavi Ravi · 2020 · Current Topics in Medicinal Chemistry
  77. Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells
    Xiaoxiao Wang, Ran Zhang, Zhen‐Li Huang, Sibin Zang, Qiuling Wu, Linghui Xia · 2021 · Transplant Immunology
  78. Lipid modification of proteins
    Marilyn D. Resh · 2021 · Elsevier eBooks
  79. Molecular Recognition in Biomimetic Receptors
    Peter C. Knipe, Sam Thompson, Andrew D. Hamilton · 2016 · Wiley eBooks
  80. Proteomic Analysis of Protein–Lipid Modifications: Significance and Application
    Kiall F. Suazo, Garrett L. Schey, Chad Schaber, Audrey R. Odom John, Mark Dewey Distefano · 2019 · Wiley eBooks
  81. Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
    Jaehee V. Shim, Douglas Chung, Alison Smith, Shivani Malik, Binaifer Balsara, Francis Burrows, PH van der Graaf, Amitava Mitra · 2026 · Clinical Pharmacology & Therapeutics
  82. Mechanistic insights on spatiotemporal control of Ras-signaling
    Clotilde Charrier, Sascha Mrachacz, Sabrina Schulze, Michael Lammers · 2026 · Biological Chemistry
  83. Statins in chronic liver disease and its complications: An umbrella review and meta-analysis of systematic reviews
    Filippo Cattazzo, Felice Cinque, Vincenzo di Maria, Marco Vicardi, Anna Mantovani, Mirko Zoncapè, Leonardo Antonio Natola, David Sacerdoti, Rosa Lombardi, Andrea Dalbeni · 2026 · Digestive and Liver Disease
  84. Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study
    Marcela de Oliveira Silva, Graziella Ribeiro de Sousa, Sarah C. Simões, Patrícia Nicolucci, Edwin Tamashiro, Fabiano Pinto Saggioro, Ricardo Santos de Oliveira, María Sol Brassesco · 2021 · Child s Nervous System
  85. Towards an Improvement of Anticancer Activity of Benzyl Adenosine Analogs
    Verdiana Covelli, Manuela Grimaldi, Rosario Randino, Mohammad Firoznezhad, Maria Proto, Veronica De Simone, Gianluca Matteoli, Patrizia Gazzerro, Maurizio Bifulco, Anna Maria D’Ursi et al. · 2021 · Molecules
  86. SYNFORM ISSUE 2013/9
    Matteo Zanda · 2013 · Synlett
  87. Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity
    Ballari, María Sol, O. J. Porta, Exequiel, Zalazar, Evelyn Arel, Etichetti, Carla M. Borini, Padrón, José M., Girardini, Javier E., Labadie, Guillermo R. · 2023 · Bioorganic & Medicinal Chemistry
  88. Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer
    NiJiati AiErken, Nan Shao, Yuhong Liu, Huijuan Shi, Yawei Shi, Zhongyu Yuan, Ying Lin · 2023 · Breast Care
  89. Design and Evaluation of Bivalent K‐Ras Inhibitors That Target the CAAX Binding Site and the Acidic Surface of Farnesyltransferase and Geranylgeranyltransferase I
    Naomi Horiuchi, Rania Omer, Fumitoshi Sugino, Nanami Ogino, Yoshihisa Inoue, Aslamuzzaman Kazi, Takeyuki Suzuki, Saı̈d M. Sebti, Junko Ohkanda · 2025 · Chemistry - A European Journal
  90. Prenylation controls proliferation in human pluripotent stem cell-derived cardiomyocytes
    Christopher A. P. Batho, Janice D. Reid, Harley Robinson, Henrietta Cserné Szappanos, Lynn Devilée, Sharon M. Hoyte, Rebecca L. Johnston, Rebekah Ziegman, Sarah Hassan, Lior Soday et al. · 2026 · Journal of Molecular and Cellular Cardiology Plus
  91. Sortase A-Mediated Farnesylation of Cdc42 In Vitro
    Sophie Tschirpke, Nynke Marije Hettema, Benjamin Spitzbarth, Mark A. R. de Geus, Frank van Opstal, Rienk Eelkema, Liedewij Laan · 2026 · ACS Synthetic Biology
  92. Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
    Constance Agamasu, Peter H. Frank, Shelley C. Perkins, Timothy J. Waybright, Simon A. J. Messing, William Gillette, Andrew G. Stephen · 2020 · Journal of Visualized Experiments
  93. Mechanisms of CaaX Protein Processing: Protein Prenylation by FTase and GGTase-I
    Melanie J. Blanden, Sudhat Ashok, James L. Hougland · 2020 · Elsevier eBooks
  94. Dual-Stage Neutral Loss Tandem Mass Spectrometric Strategy for Confident Identification of Protein Prenylation
    Zixiang Fang, Saiful M. Chowdhury · 2021 · Analytical Chemistry
  95. Structure and Function of the mTOR Activator Rheb
    Christopher B. Marshall, Mohammad T. Mazhab‐Jafari, Vuk Stambolic, Mitsuhiko Ikura · 2014 · Springer eBooks
  96. Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of Tsc2-Null Cells
    Marisol E. Armijo, Emilia Escalona, Daniela Peña, Alejandro Farías, Violeta Morı́n, Matthias Baumann, Bert Klebl, Roxana Pincheira, Ariel Fernando Castro · 2022 · Frontiers in Pharmacology
  97. Design, synthesis and membrane anchoring strength of lipidated polyaza crown ether DNA-conjugates (LiNAs) studied by DNA-controlled assembly of liposomes
    Ulla Jakobsen, Kadla Røskva Rosholm, Stefan Vogel · 2022 · Organic & Biomolecular Chemistry
  98. Label-free observation of DNA-encoded liposome fusion by surface plasmon resonance
    Philipp M. G. Löffler, Nikolaj Alexander Risgaard, Bettina L. Svendsen, Katrine Aalbæk Jepsen, Alexander Rabe, Stefan Vogel · 2023 · Chemical Communications
  99. Inactivation of Ymr1, Sjl2/3 phosphatases promotes stress resistance and longevity in wild type and Ras2G19V yeast
    Mario G. Mirisola, Valter Daniel Longo · 2023 · Biomedical Journal
  100. Comprehensive analysis of CXXX sequence space reveals that Saccharomyces cerevisiae GGTase-I mainly relies on a2X substrate determinants
    Anushka Sarkar, Emily R. Hildebrandt, Khushi V. Patel, Emily T Mai, Sumil A Shah, June H Kim, Walter K. Schmidt · 2024 · G3 Genes Genomes Genetics